Chemed Corp.【CHE】 業績推移・財務諸表

(単位:千ドル) 2Q10 3Q10 1Q11 2Q11 3Q11 1Q12 2Q12 3Q12 1Q13 2Q13 3Q13 1Q14 2Q14 3Q14 1Q15 2Q15 3Q15 1Q16 2Q16 3Q16 1Q17 2Q17 3Q17 1Q18 2Q18 3Q18 1Q19 2Q19 3Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 314,995 320,451 330,918 333,360 341,439 352,943 354,170 354,353 366,641 357,198 340,886 358,300 360,182 358,389 376,652 381,921 386,226 390,389 390,409 392,607 405,864 415,059 417,444 439,176 441,813 444,151 462,034 473,584 480,613 515,798 502,199 528,297 527,360 532,256 538,667 530,549 531,288 526,472 560,157 553,816 564,532 589,233 595,880 606,181 646,943
売上成長率(%) - - -
売上原価 223,702 227,915 237,458 239,597 245,063 257,445 257,368 256,610 264,307 255,359 243,184 257,819 257,007 256,445 268,885 270,663 272,089 278,435 276,255 281,658 285,140 285,852 288,047 304,536 305,741 305,312 321,951 323,637 328,183 351,745 352,163 339,240 340,473 350,493 342,164 336,552 336,821 346,934 370,705 374,193 362,358 385,127 389,750 396,187 430,530
販売管理費 49,956 48,200 55,654 50,424 47,618 53,167 49,770 52,955 55,560 53,107 48,870 55,671 53,649 53,566 58,588 57,994 55,197 59,045 62,628 59,373 69,458 68,654 66,919 69,000 68,297 67,177 74,029 71,556 76,836 70,583 84,513 88,317 91,599 93,838 89,217 89,954 87,853 83,992 100,095 94,987 99,602 115,873 102,255 101,981 105,587
営業費用 281,139 283,696 300,370 297,518 300,128 317,966 314,645 318,383 327,789 331,306 311,676 321,648 318,663 318,178 336,081 337,321 336,098 345,996 352,046 349,736 364,410 454,007 363,447 382,779 383,672 382,438 412,562 408,056 415,685 436,435 409,439 453,989 446,919 460,557 445,798 441,175 439,350 445,615 487,338 484,310 477,682 516,900 507,755 514,024 552,185
営業利益 33,856 36,755 30,548 35,842 41,311 34,977 39,525 35,970 38,852 25,892 29,210 36,652 41,519 40,211 40,571 44,600 50,128 44,393 38,363 42,871 41,454 -38,948 53,997 56,397 58,141 61,713 49,472 65,528 64,928 79,363 92,760 74,308 80,441 71,699 92,869 89,374 91,938 80,857 72,819 69,506 86,850 72,333 88,125 92,157 94,758
営業利益率 (%)
経常(税引前)利益 30,867 33,982 29,406 33,095 35,821 33,455 34,883 34,067 36,464 23,891 25,620 33,653 39,846 39,936 40,165 44,167 46,865 40,627 40,609 43,493 42,922 -38,416 54,272 56,208 57,655 62,931 50,787 64,304 66,923 68,922 99,623 81,604 83,662 75,105 95,420 84,702 86,106 76,471 71,165 70,344 93,265 84,485 93,828 101,029 95,674
経常(税引前)利益率(%) 9.8 10.6 8.89 9.93 10.49 9.48 9.85 9.61 9.95 6.69 7.52 9.39 11.06 11.14 10.66 11.56 12.13 10.41 10.4 11.08 10.58 -9.26 13.0 12.8 13.05 14.17 10.99 13.58 13.92 13.36 19.84 15.45 15.86 14.11 17.71 15.96 16.21 14.53 12.7 12.7 16.52 14.34 15.75 16.67 14.79
法人税等合計 12,012 12,994 11,305 12,809 13,934 13,010 13,609 13,222 14,186 9,283 8,188 13,079 15,483 15,351 15,628 17,192 18,032 15,787 15,724 16,664 13,078 -16,760 18,835 11,212 2,684 11,682 6,120 13,575 7,976 13,031 17,522 13,882 18,262 18,583 23,417 20,533 19,650 19,598 17,044 16,967 18,307 19,468 22,941 25,253 23,917
実効税率(%)
純利益 18,855 20,988 18,101 20,286 21,887 20,445 21,274 20,845 22,278 14,608 17,432 20,574 24,363 24,585 24,537 26,975 28,833 24,840 24,885 26,829 29,844 -21,656 35,437 44,996 54,971 51,249 44,667 50,729 58,947 55,891 82,101 67,722 65,400 56,522 72,003 64,169 66,456 56,873 54,121 53,377 74,958 65,017 70,887 75,776 71,757
純利益率(%)
一株あたり利益 0.83 0.93 0.86 0.96 1.06 1.08 1.12 1.1 1.2 0.79 0.96 1.17 1.41 1.44 1.45 1.6 1.71 1.49 1.51 1.66 1.84 -1.35 2.22 2.79 3.43 3.19 2.8 3.18 3.69 3.5 5.16 4.25 4.08 3.57 4.62 4.28 4.45 3.82 3.62 3.54 4.97 4.3 4.7 5.04 4.91
希薄化後一株あたり利益 0.82 0.91 0.84 0.94 1.04 1.06 1.1 1.07 1.17 0.77 0.94 1.12 1.36 1.39 1.4 1.55 1.65 1.45 1.48 1.62 1.78 -1.35 2.13 2.66 3.27 3.06 2.7 3.08 3.56 3.38 5.01 4.14 4.01 3.51 4.55 4.22 4.4 3.78 3.58 3.51 4.93 4.24 4.65 5 4.86
一株あたり配当金 0.12 0.14 0.14 0.14 0.16 0.16 0.16 0.18 0.18 0.18 0.2 0.2 0.2 0.22 0.22 0.22 0.24 0.24 0.24 0.26 0.26 0.26 0.28 0.28 0.28 0.3 0.3 0.3 0.32 0.32 0.32 0.34 0.34 0.34 0.36 0.36 0.36 0.38 0.38 0.38 0.4 0.4 0.4 0.5 0.5
EBITDA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -